A Renal Impairment Study for PF-04965842
NCT03660241
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class
Conditions
Renal Impairment
Interventions
DRUG:
PF-04965842
Sponsor
Pfizer